Literature DB >> 22246849

Insulin sensitivity modifies the relationship between thyroid function and lipid profile in euthyroid type 1 diabetic patients.

Tomislav Bulum1, Branko Kolarić, Lea Duvnjak.   

Abstract

It has been suggested that association between hypothyroidism with dyslipidemia might be present already at the stage of normal thyroid function through altered insulin sensitivity. We analyzed the role of insulin sensitivity as a mediator of thyroid-induced lipid changes in euthyroid type 1 diabetic patients. Study included 304 patients with type 1 diabetes and normal thyroid function. Insulin sensitivity was measured with estimated glucose disposal rate calculated using the equation: eGDR = 24.31 - (12.22 × WHR) - (3.29 × HT) - (0.57 × HbA1c); WHR = waist-to-hip ratio, HT = hypertension. TSH, FT4, FT3, and serum lipids were measured. Correlations and multiple linear regressions analysis were performed to identify relationships between thyroid status and serum lipid parameters after stratifying patients in quartiles of eGDR. After adjustment for age, sex, BMI, duration of diabetes and insulin dose TSH, FT3, and FT4 was not significantly associated with serum lipids in all patients, independently of level of insulin sensitivity. However, after stratifying patients for the degree of insulin sensitivity in subjects in the lowest quartile of insulin sensitivity TSH was independently associated with LDL cholesterol (β = 0.210, p = 0.02). The independent relation of eGDR with TSH and LDL cholesterol suggests that the influence of thyroid function on lipid metabolism might extend into euthyroid range through altered insulin sensitivity.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22246849     DOI: 10.1007/s12020-012-9598-y

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  38 in total

Review 1.  The metabolic syndrome.

Authors:  Robert H Eckel; Scott M Grundy; Paul Z Zimmet
Journal:  Lancet       Date:  2005 Apr 16-22       Impact factor: 79.321

2.  Insulin resistance, the metabolic syndrome, and complication risk in type 1 diabetes: "double diabetes" in the Diabetes Control and Complications Trial.

Authors:  Eric S Kilpatrick; Alan S Rigby; Stephen L Atkin
Journal:  Diabetes Care       Date:  2007-03       Impact factor: 19.112

3.  Interactions among thyroid function, insulin sensitivity, and serum lipid concentrations: the Fremantle diabetes study.

Authors:  S A P Chubb; W A Davis; T M E Davis
Journal:  J Clin Endocrinol Metab       Date:  2005-06-28       Impact factor: 5.958

4.  Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects.

Authors:  Annemieke Roos; Stephan J L Bakker; Thera P Links; Rijk O B Gans; Bruce H R Wolffenbuttel
Journal:  J Clin Endocrinol Metab       Date:  2006-11-07       Impact factor: 5.958

Review 5.  The interface between thyroid and diabetes mellitus.

Authors:  Leonidas H Duntas; Jacques Orgiazzi; Georg Brabant
Journal:  Clin Endocrinol (Oxf)       Date:  2011-07       Impact factor: 3.478

6.  TSH-controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: a double blind, placebo-controlled trial (Basel Thyroid Study).

Authors:  C Meier; J J Staub; C B Roth; M Guglielmetti; M Kunz; A R Miserez; J Drewe; P Huber; R Herzog; B Müller
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

7.  Insulin resistance in insulin-dependent diabetic patients with microalbuminuria.

Authors:  J Yip; M B Mattock; A Morocutti; M Sethi; R Trevisan; G Viberti
Journal:  Lancet       Date:  1993-10-09       Impact factor: 79.321

8.  The relationship of acute insulin sensitivity to the progression of vascular disease in long-term type 1 (insulin-dependent) diabetes mellitus.

Authors:  F I Martin; J L Hopper
Journal:  Diabetologia       Date:  1987-03       Impact factor: 10.122

9.  Lipoprotein alterations, hepatic lipase activity, and insulin sensitivity in subclinical hypothyroidism: response to L-T(4) treatment.

Authors:  Gabriela Brenta; Gabriela Berg; Pablo Arias; Valeria Zago; Marta Schnitman; Maria Luz Muzzio; Isaac Sinay; Laura Schreier
Journal:  Thyroid       Date:  2007-05       Impact factor: 6.568

10.  Lipid abnormalities and cardiometabolic risk in patients with overt and subclinical thyroid disease.

Authors:  Melpomeni Peppa; Grigoria Betsi; George Dimitriadis
Journal:  J Lipids       Date:  2011-07-18
View more
  2 in total

1.  Relation of thyroid hormone abnormalities with subclinical inflammatory activity in patients with type 1 and type 2 diabetes mellitus.

Authors:  Arnaldo Moura Neto; Maria Candida Ribeiro Parisi; Sarah Monte Alegre; Elizabeth Joao Pavin; Marcos Antonio Tambascia; Denise Engelbrecht Zantut-Wittmann
Journal:  Endocrine       Date:  2015-06-07       Impact factor: 3.633

2.  The thyroid hormone levels and glucose and lipid metabolism in children with type 1 diabetes: a correlation analysis.

Authors:  Chuanjie Yuan; Xiaomei Sun; Yin Liu; Jin Wu
Journal:  Transl Pediatr       Date:  2021-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.